Journal of cancer research and clinical oncology
-
J. Cancer Res. Clin. Oncol. · Jan 2005
Clinical Trial Controlled Clinical TrialThe benefit of bone-seeking radiopharmaceuticals in the treatment of metastatic bone pain.
The surface bone-seeking radiopharmaceuticals rhenium-188-HEDP (188Re-HEDP) and samarium-153-EDTMP (153Sm-EDTMP) were investigated to determine the efficacy and toxicity in pain palliation in bone metastases. ⋯ Both radiopharmaceuticals were effective in pain palliation, without induction of severe side effects or significant differences in therapeutic efficacy or toxicity.